drugset / Trial / NCT06539273

Exosome Treatment in Androgenetic Alopecia

NCT06539273 ↗

Phase 3 Completed 30 enrolled Yeditepe University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aims to elucidate the effect of "foreskin-derived mesenchymal stromal cells derived exosome" injection into the scalp on hair density in patients with androgenetic alopecia and the contribution of this treatment on patient satisfaction.

Timeline

Start
2024-01-01
Primary completion
2024-04-30
Completion
2024-05-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Exosome Complex, RNA Unknown 3 ml Other

Indications